Murakami Takashi, Hiroshima Yukihiko, Zhao Ming, Zhang Yong, Chishima Takashi, Tanaka Kuniya, Bouvet Michael, Endo Itaru, Hoffman Robert M
AntiCancer Inc., San Diego, California, USA.
Department of Surgery, University of California, San Diego, California, USA.
Oncotarget. 2015 Oct 13;6(31):31368-77. doi: 10.18632/oncotarget.5187.
Liver metastasis is the most frequent cause of death from colon and other cancers. Generally, liver metastasis is recalcitrant to treatment. The aim of this study is to determine the efficacy of tumor-targeting Salmonella typhimurium A1-R on liver metastasis in orthotopic mouse models. HT-29 human colon cancer cells expressing red fluorescent protein (RFP) were used in the present study. S. typhimurium A1-R infected HT-29 cells in a time-dependent manner, inhibiting cancer-cell proliferation in vitro. S. typhimurium A1-R promoted tumor necrosis and inhibited tumor growth in a subcutaneous tumor mouse model of HT-29-RFP. In orthotopic mouse models, S. typhimurium A1-R targeted liver metastases and significantly reduced their growth. The results of this study demonstrate the future clinical potential of S. typhimurium A1-R targeting of liver metastasis.
肝转移是结肠癌和其他癌症最常见的死亡原因。一般来说,肝转移对治疗具有抗性。本研究的目的是确定肿瘤靶向性鼠伤寒沙门氏菌A1-R对原位小鼠模型肝转移的疗效。本研究使用了表达红色荧光蛋白(RFP)的HT-29人结肠癌细胞。鼠伤寒沙门氏菌A1-R以时间依赖性方式感染HT-29细胞,在体外抑制癌细胞增殖。在HT-29-RFP皮下肿瘤小鼠模型中,鼠伤寒沙门氏菌A1-R促进肿瘤坏死并抑制肿瘤生长。在原位小鼠模型中,鼠伤寒沙门氏菌A1-R靶向肝转移灶并显著抑制其生长。本研究结果证明了鼠伤寒沙门氏菌A1-R靶向肝转移在未来临床应用中的潜力。